Maximus, Inc. (NYSE:MMS) Shares Purchased by IFP Advisors Inc

IFP Advisors Inc boosted its holdings in shares of Maximus, Inc. (NYSE:MMS) by 62.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 786 shares of the health services provider’s stock after acquiring an additional 302 shares during the period. IFP Advisors Inc’s holdings in Maximus were worth $59,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of MMS. Nordea Investment Management AB acquired a new position in shares of Maximus during the 4th quarter worth approximately $4,618,000. Fort Washington Investment Advisors Inc. OH raised its holdings in shares of Maximus by 39.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider’s stock worth $22,132,000 after acquiring an additional 83,390 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Maximus in the fourth quarter valued at $1,113,000. Versor Investments LP boosted its stake in shares of Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock valued at $792,000 after acquiring an additional 5,789 shares during the last quarter. Finally, Legato Capital Management LLC boosted its stake in shares of Maximus by 33.9% during the fourth quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider’s stock valued at $2,399,000 after acquiring an additional 8,138 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Price Performance

Shares of NYSE:MMS opened at $67.97 on Friday. The company has a market cap of $3.85 billion, a P/E ratio of 14.62 and a beta of 0.72. The business has a fifty day simple moving average of $72.91 and a 200-day simple moving average of $80.49. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were issued a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.77%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Insider Activity

In other Maximus news, CEO Bruce Caswell purchased 3,500 shares of Maximus stock in a transaction on Tuesday, December 17th. The shares were purchased at an average cost of $70.64 per share, with a total value of $247,240.00. Following the completion of the transaction, the chief executive officer now directly owns 275,929 shares in the company, valued at approximately $19,491,624.56. This represents a 1.28 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Raymond B. Ruddy acquired 3,490 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was acquired at an average cost of $71.46 per share, with a total value of $249,395.40. Following the transaction, the director now directly owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This represents a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 7,008 shares of company stock valued at $497,835 in the last ninety days. Company insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on MMS shares. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.